Blog Archives

PRESS RELEASE: Great Lakes NeuroTechnologies Secures $1.7 Million to Develop Continuous Dyskinesia Monitoring Technology for Parkinson’s Disease

VIEW PRESS RELEASE [PDF]

 05 Mar 2013: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today that they are launching commercialization and clinical studies to validate a system for objective, continuous monitoring of dyskinesias associated with Parkinson’s disease. The study is being funded by a $1,743,051 Phase II Small Business Innovative Research grant from the National Institutes of Health (NIH),

Read more ›



PRESS RELEASE: Great Lakes NeuroTechnologies Launches Study to Develop Intelligent Algorithms for Programming Deep Brain Stimulation in Parkinson’s

VIEW PRESS RELEASE [PDF]

22 JAN 2013: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today that they are launching a study to determine the feasibility of using intelligent algorithms to assist with programming deep brain stimulation settings for Parkinson’s disease.   The study is being funded by a $283,828 Phase I Small Business Innovative Research grant from the National Institutes of Health,

Read more ›



PRESS RELEASE: Great Lakes NeuroTechnologies’ Kinesia Technology Receives TGA Approval for Parkinson’s Assessment in Australia

VIEW PRESS RELEASE [PDF]

9 JAN 2013: Valley View, OH – Great Lakes NeuroTechnologies announced today that they received TGA approval to market Kinesia technology in Australia. The Kinesia™ product line [ http://glneurotech.com/kinesia/ ] includes patient-worn motion sensors and a tablet computer to quantitatively assess tremor,

Read more ›



Active-Assisted Cycling Improves Tremor and Bradykinesia in Parkinson’s Disease

A. Ridgel, C. Peacock, E. Fickes, C. Kim
Arch Phys Med Rehabil. 2012 Nov;93(11):2049-54

Read more ›



PRESS RELEASE: GLNT Receives $1.5 Million to Further Technology for Assessing Bradykinesia Response to Novel Therapies in Parkinson’s Disease

VIEW PRESS RELEASE [PDF]

08 AUG 2012: Valley View, OH – Great Lakes NeuroTechnologies [ http://www.glneurotech.com ] announced today that they have received $1.5 million in funding to commercialize a technology for Parkinson’s disease (PD) patients that will better assess motor symptoms in response to new deep brain stimulation (DBS) and pharmaceutical therapies. 

Read more ›



PRESS RELEASE: GLNT Launches Parkinson’s Technology In Europe For Quantitative Assessments In Telemedicine

VIEW PRESS RELEASE [PDF]

13 JUN 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that they are launching the latest version of their medical device technology for assessing Parkinson’s disease next week at the Movement Disorders Society Congress in Dublin, Ireland.  The Kinesia HomeView™ [ http://glneurotech.com/kinesia/homeview/  ] system includes patient-worn motion sensors and a tablet computer to quantitatively assess tremor,

Read more ›



PRESS RELEASE: GLNT Issued Patent Claims For Technology To Assess Parkinson’s Disease

VIEW PRESS RELEASE [PDF]

6 JUN 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that the U.S. Patent Office has issued claims under patent number 8,187,209 covering their Movement Disorder Monitoring System and Method for quantitative assessment of motor symptoms associated with movement disorders.  

Read more ›



Patient Compliance with Parkinson’s Disease Home Monitoring System

Danielle Filipkowski, Dustin Heldman, Alberto Espay, Jaya Mishra, Thomas Mera, and J. Giuffrida
16th International Congress of Parkinson’s Disease and Movement Disorders, Dublin, Ireland 2012

Read more ›



Capturing Choreatic Dyskinesia Over Levodopa Dose Cycle in Parkinson’s Disease

T. Mera, Michelle Burack, MD, PhD, Frank Bonsignore, MS, J. Giuffrida, PhD
16th International Congress of Parkinson’s Disease and Movement Disorders, Dublin, Ireland 2012

Read more ›



Intra- and Multi-Day Home-Based Monitoring of Parkinson’s Disease Motor Symptoms

D. Heldman, D. Filipkowski, A. Espay, Jaya Mishra,J. Giuffrida
16th International Congress of Parkinson’s Disease and Movement Disorders, Dublin, Ireland 2012

Read more ›



Top